Showing results (321-330 of 331) with videos related to
Sort By:
Pageof 34
Cancer Research|February 1, 1990
Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibodyB A Parker, A B Vassos, S E Halpern, et al.American Journal of Clinical Oncology|April 1, 1993
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group BS D Luikart, M Goutsou, E D Mitchell, et al.American Journal of Clinical Oncology|February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)S D Luikart, J E Herndon, D R Hollis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B studyR C Lilenbaum, M J Ratain, A A Miller, et al.Cancer Treatment Reports|June 1, 1982
Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lungJ A Young, R O Dillman, S L Seagren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group BT A Ahles, P M Silberfarb, J Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B studyL H Maurer, J E Herndon, D R Hollis, et al.Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerM L Rothenberg, M J Moore, M C Cripps, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialH A Burris, M J Moore, J Andersen, et al.Pageof 34